Skip to main content
. 2016 Jun 7;7(27):41285–41293. doi: 10.18632/oncotarget.9778

Figure 1. The prognostic role of AR alone in different population and stratified by joint hormone receptor (HR) status.

Figure 1

Cumulative Disease-free Survival(DFS) curves of a. all patients (n = 407), b. Luminal subtype patients (n = 185), c. TNBC patients (n = 137), d. HER2 positive patients (n = 85), e. combinations of AR and HR status.